Results from two African studies of pre-exposure prophylaxis, or PrEP, released on July 13, 2011 provide clear evidence that the antiretroviral drugs used to treat HIV can also be used to prevent HIV among heterosexual men and women at risk of HIV infection.

For more about the PrEP study in Tororo and Mbale